Larazotide Dosage and Protocols
Larazotide dosage protocols reported in published research, plus reconstitution and storage.
Phase 2 Trial Dosing
The only dose with meaningful supporting data is 0.5mg orally, three times daily, the regimen used in the positive Phase 2 trial. Higher doses tested in the same trial showed no additional benefit. No FDA-approved or otherwise validated dosing schedule exists beyond this trial protocol.
Reported protocol doses
Standard dose0.5 mg
Frequency3x daily
Routesoral
Doses shown are those reported in published research, not a recommendation.